Hydroxypropyl chitosan bearing β-cyclodextrin cavities:: Synthesis and slow release of its inclusion complex with a model hydrophobic drug

被引:82
作者
Prabaharan, M
Mano, JF
机构
[1] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4710057 Braga, Portugal
[2] Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal
关键词
beta-cyclodextrin; chitosan; controlled release; hydrophobic drug; inclusion complex;
D O I
10.1002/mabi.200500087
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydroxypropyl chitosan-graft-carboxymethyl beta-cyclodextrin (HPCH-g-CM beta-CD) was synthesized by grafting CM beta-CD onto HPCH using water soluble 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) as the condensing agent. Due to the presence of hydrophobic beta-CD rings onto the HPCH backbone, this polymer can be used as a matrix for controlled drug release. The adsorption of a hydrophobic model drug, ketoprofen, by HPCH-g-CM beta-CD microparticles (using tripolyphosphate as an ionic cross-linking agent) fitted well in the Langmuir isotherm equation. The drug dissolution profile showed that HPCH-g-CM beta-CD microparticles provided a slower release of the entrapped ketoprofen than chitosan, and the release behavior was influenced by the pH value of the medium. These results suggest that beta-CD grafted with chitosan derivatives may become a potential biodegradable delivery system to control the release of hydrophobic drugs with pH-responsive capability.
引用
收藏
页码:965 / 973
页数:9
相关论文
共 39 条
[11]   Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxypropyl-β-cyclodextrin inclusion complex [J].
Filipovic-Grcic, J ;
Voinovich, D ;
Moneghini, M ;
Becirevic-Lacan, M ;
Magarotto, L ;
Jalsenjak, I .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 9 (04) :373-379
[12]   Industrial applications of cyclodextrins [J].
Hedges, AR .
CHEMICAL REVIEWS, 1998, 98 (05) :2035-2044
[13]   Water-soluble N-(n-fatty acyl)chitosans [J].
Hirano, S ;
Yamaguchi, Y ;
Kamiya, M .
MACROMOLECULAR BIOSCIENCE, 2003, 3 (10) :629-631
[14]  
Illum L, 1998, PHARM RES-DORDR, V15, P1326
[15]  
KAY HS, 2001, PAIN, V93, P23
[16]   Preparation of a dipalmitoylphosphatidylcholine/cholesterol Langmuir-Blodgett monolayer that suppresses protein adsorption [J].
Kim, K ;
Kim, C ;
Byun, Y .
LANGMUIR, 2001, 17 (16) :5066-5070
[17]   Preparation and characterization of chitosan microparticles intended for controlled drug delivery [J].
Ko, JA ;
Park, HJ ;
Hwang, SJ ;
Park, JB ;
Lee, JS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) :165-174
[18]   Preparation of chitosan self-aggregates as a gene delivery system [J].
Lee, KY ;
Kwon, IC ;
Kim, YH ;
Jo, WH ;
Jeong, SY .
JOURNAL OF CONTROLLED RELEASE, 1998, 51 (2-3) :213-220
[19]  
Loftsson T., 1997, PHARM TECHNOL EUR, V9, P26
[20]   Preparation of water-soluble chitosan [J].
Lu, SJ ;
Song, XF ;
Cao, DY ;
Chen, YP ;
Yao, KD .
JOURNAL OF APPLIED POLYMER SCIENCE, 2004, 91 (06) :3497-3503